Ludwig WD, Lasek R, Adam D, Barker M, Bauer T, Dalhoff K, etal. (2013). "Atemwegsinfektionen [Airway Infections]"[Drug prescription in practice] (PDF). Arzneiverordnung in der Praxis (in German) (3rded.). Arzneimittelkommission der deutschen Ärzteschaft [Medicinal Products Committee of the German Medical Association] . Retrieved July 27, 2021. a b c Wittig T (2010). GeloMyrtol forte standardised – Eine klinische Dokumentation [A clinical documentation] (5thed.). Ergebnisse Verlag. p.23. ISBN 978-3-540-00983-2. Koch AK, Klose P, Lauche R, Cramer H, Baasch J, Dobos GJ, Langhorst J (2016). "A Systematic Review of Phytotherapy for Acute Rhinosinusitis". Forschende Komplementärmedizin. 23 (3): 165–9. doi: 10.1159/000447467. PMID 27404100. S2CID 13152708. Furthermore, GeloSitin® gently removes existing crusts and scabs. The practical spray head allows to distribute the fine spray of GeloSitin® optimally in the nose. Orange and lemon oils provide the nose care with a pleasant smell.

GELOMYRTOL forte caps. 100 pc sinusitis, paranasal sinuses UK

a b "COPD-Patienten profitieren von prophylaktischer Gabe". Pharmazeutische Zeitung (PZ). Avoxa - Mediengruppe Deutscher Apotheker GmbH. July 2017 . Retrieved October 7, 2021. Išgrynintų eukaliptų, saldžiųjų apelsinų, mirtų ir citrinų eterinių aliejų mišinio (66:32:1:1) distiliatas There are no concerns about long-term use. GeloMyrtol ® forte is also used successfully for chronic bronchitis and sinusitis. In decades of therapeutic use in clinics and practices, it has proven to be very well tolerated and effective. Many patients with chronic sinusitis or chronic bronchitis have had very good experiences with the permanent use of GeloMyrtol ® forte over the years. In patients with chronic bronchitis, it was possible to show in a large clinical study over 6 months that the administration of GeloMyrtol ® forte, the intensity and frequency of acute infections could be significantly reduced over the winter months. * Mucolytic (mucus-breaking) action: In one in vitro study, sputum samples of patients with bronchial asthma, chronic bronchitis and cystic fibrosis were examined. After addition of ELOM-080, the viscoelasticity of the sputum decreased by approximately 10 to 16%. These values are comparable with effects of N- acetylcysteine. [11]

Gelomyrtol forte 300mg skrandyje neirios kapsulės N20

Jedna GeloMyrtol forte gastrorezistentna kapsula, meka sadrži 300mg smeše etarskih ulja eukaliptusa (Eucalypti aetheroleum), slatke narandže (Aurantii dulcis), mirte (Myrti aetheroleum) limuna (Limonis aetheroleum) (66:32:1:1), standardizovane na 1,8-cineol (75mg), d-limonen (75mg), i (+)-alfa-pinen (20mg).

based management of acute rhinosinusitis with herbal Evidence-based management of acute rhinosinusitis with herbal

Pomoćne supstance koje ulaze u sastav kapsule su: želatin; glicerol 85%; sorbitol, tečni (nekristal- išući); hipromeloza-ftalat; dibutilftalat; hlorovodonična kiselina Vienoje skrandyje neirioje minkštojoje kapsulėje yra 300mg i šgrynintų eukaliptų, saldžiųjų apelsinų, mirtų ir citrinų eterinių aliejų mišinio (66:32:1:1) distiliato . GeloMyrtol forte sadrži smešu etarskih ulja eukaliptusa (Eucalypti aetheroleum), slatke narandže (Aurantii dulcis), mirte (Myrti aetheroleum) i limuna (Limonis aetheroleum) (66:32:1:1), standardizovane na 1,8-cineol (75mg), dlimonen (75mg), i (+)-alfapinen (20mg) i ublažava simptome akutnih i hroničnih oblika bronhitisa i sinuzitisa. In a further double-blind, randomised and placebo-controlled study (RCT), ELOM-080 and an essential oil were administered to a total of 331 adults with acute nasal sinus inflammations (acute sinusitis) for approximately one week and compared with a sham preparation (placebo). To prevent distortions, neither the clinical investigators nor the patients knew what was being administered as the preparation in the individual case ( double blinding), and the assignment to the three groups was based on the principle of chance ( randomization). The comparison of the symptom total scores of the study participants revealed statistically significant superiority of the ELOM-080 active ingredient compared with the patients treated with the placebo. In other words, the patients recovered faster, especially in relation to the key symptoms of headaches, pain while bending over and sensitivity to pressure over the nasal sinuses. After this therapy phase, antibiotic treatments were needed much less often in the ELOM-080 group than in the placebo group (7% versus 13%). [31] Chronic sinusitis [ edit ] A non-interventional studies conducted in 2018 once again confirmed the efficacy of ELOM-080 in the treatment of acute rhinosinusitis. [28] In total, 223 patients with diagnosed rhinosinusitis and aged between 18 and 86 years participated in the study. 114 patients were treated with ELOM-080 (GeloMyrtol® forte) by the attending doctors. All patients were observed over a period of at most 14 days, after which they described their symptoms associated with the acute rhinosinusitis (ARS) on a numerical scale. In addition, the tolerability was questioned, as was the assessment of the treating doctor as to efficacy and tolerability. In the ELOM-080 study arm, effective alleviation of facial pain, the key symptom of ARS, was observed almost immediately. This trend continued over the entire treatment period. Clear improvements were likewise found with respect to further symptoms, such as headaches, stuffy nose, pain in the nasal sinuses upon percussion and pressure sensitivity of the trigeminal nerve exit points. The patients were also satisfied with the improvement of their general feeling of illness. With respect to gastrointestinal tolerability for ELOM-080, the patients were found to be satisfied to very satisfied regardless of the time of ingestion of the medicine. [29] [30]

Baldurat®

Our airways supply the entire body with vital oxygen. As a result, respiratory infections affect our entire sense of well-being. A stuffy nose and congested bronchi require fast treatment. Our Gelo – strength for the respiratory tract product range offers various plant-based medications to treat the different symptoms of these illnesses. In a post-hoc analysis of the study, patients with chronic bronchitis and simultaneously suffering from COPD (chronic obstructive pulmonary disease) were investigated. 64 patients met this criterion. Even for those patients with COPD, ELOM-080 reduced the number of exacerbations during the winter season. The number of patients with at least one exacerbation was statistically significantly smaller than under the sham treatment (29% vs. 55%). The patients felt much less impaired by coughing and sputum under the therapy with ELOM-080, and they evaluated their state of health more often as good or very good in comparison with a sham therapy. [38] [36] [39] In this connection, both treatments had comparable tolerability. Kaschke O, Behrbohm H, Sydow K (1997). "The influence of a secretolytic drug on mucociliary clearance of the maxillary sinus" (PDF). Journal of Rhinology. 4 (1): 29–33. ISSN 1229-1498 . Retrieved June 22, 2021.

PACKAGE LEAFLET: Information for the user - Gelomyrtol® forte PACKAGE LEAFLET: Information for the user - Gelomyrtol® forte

Note: This declaration is only valid for Germany. Regulatory information may possibly differ in other countries. The product is well tolerated, preservative-free and suitable for children from three years and can also be used during pregnancy and breastfeeding. Imajte u vidu da se ove informacije mogu odnositi i na lekove koje više ne pijete, kao i na lekove koje planirate da uzimate u budućnosti. Obavestite svog lekara ili farmaceuta ako uzimate, ili ste do nedavno uzimali neki drugi lek, uključujući i lek koji se nabavlja bez lekarskog recepta. Matthys H, de Mey C, Carls C, Ryś A, Geib A, Wittig T (August 2000). "Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol". Arzneimittel-Forschung. Editio Cantor Verlag. 50 (8): 700–11. doi: 10.1055/s-0031-1300276. PMID 10994153. S2CID 39472417.

Secretolytic (mucus-liquefying) action: A mucus-liquefying effect has been observed in mice under administration of ELOM-080. In a direct comparison with untreated animals, the secretolytic action was increased by 32%. It was also increased by 21% during treatment with a pure eucalyptus oil preparation. [15] According to studies, this effect is to be attributed to increased chloride ion efflux, which leads to an osmotic gradient across the mucous membranes and in turn to passive water efflux. [14] The increased hydration of the mucus leads to its liquefaction. Observational study by Wittig (2014). GeloProsed® im Alltag. Pharmazeutische Zeitung 159(47): 3932-8 Bronchitis becomes dangerous whenever there is difficulty in breathing or there is a risk that the inflammation will spread to the lungs. If there is a high fever, chills or bloody discoloration in the sputum, a doctor should be alerted immediately. Patients with a weakened immune system and previous lung diseases are particularly at risk.